S1304, Testing Two Doses of Carfilzomib With Dexamethasone for Relapsed or Refractory Myeloma

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentActive18 and overNCI, OtherS1304
U10CA032102, NCI-2013-00796, NCT01903811

Trial Description

Summary

This randomized phase II trial studies how well two doses of carfilzomib work with dexamethasone in treating patients with relapsed or refractory multiple myeloma. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving carfilzomib together with dexamethasone may kill more cancer cells. This study is looking to see if giving a higher or lower dose of carfilzomib with dexamethasone is more beneficial than the other.

Further Study Information

PRIMARY OBJECTIVES:

I. To evaluate and compare progression free survival (PFS) of two different doses of carfilzomib with dexamethasone in multiple myeloma (MM) patients with relapsed and/or refractory disease.

SECONDARY OBJECTIVES:

I. To evaluate and compare response rates (RR) for each arm. II. To evaluate response rates (RR) for patients that relapse on low dose carfilzomib and subsequently cross-over to high dose carfilzomib.

III. To evaluate the safety of this combination for this patient population. IV. To evaluate overall survival (OS).

TERTIARY OBJECTIVES:

I. To explore the molecular variability in MM cells obtained from extramedullary bone marrow relapse sites.

II. To explore the role of positron emission tomography (PET) scanning in assessing disease burden and as a tool to assess treatment response.

III. To explore changes in left ventricular ejection fraction (LVEF) in patients with relapsed or refractory multiple myeloma treated with low dose carfilzomib or high dose carfilzomib plus dexamethasone.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients receive dexamethasone intravenously (IV) and low-dose carfilzomib IV over 2-10 minutes on days 1, 2, 8, 9, 15, and 16. Patients with progression cross-over to Arm II.

ARM II: Patients receive dexamethasone IV and high-dose carfilzomib IV over 30 minutes on days 1, 2, 8, 9, 15, and 16.

Note that for the first course of treatment on both arms carfilzomib is given at a reduced rate to assess toxicity.

In both arms, treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up for 3 years from initial registration.

Eligibility Criteria

  • REGISTRATION STEP 1: INITIAL RANDOMIZATION
  • Patients must have a confirmed diagnosis of symptomatic multiple myeloma and must be relapsed or refractory; all tests for establishing disease status must be completed within 28 days prior to registration and documented on the Baseline Tumor Assessment Form for Multiple Myeloma
  • Patients must have measurable disease within 28 days prior to registration
  • Patients must have received at least one prior regimen of chemotherapy for symptomatic multiple myeloma; patients may not have more than six (6) previous regimens of therapy for the disease; prior chemotherapy must have been completed at least 28 days prior to registration; for study purposes, a regimen is defined as follows:
  • An anti-myeloma therapy used at the time of initial diagnosis or documented disease progression which is given with the intent to decrease disease burden
  • Any maintenance therapy used after an Induction should be considered part of that Induction regimen
  • Use of any agent or combination of agents more than once during the patient's disease history for separate documented disease progressions will be counted as separate regimens (e.g., if a patient receives lenalidomide/bortezomib at initial diagnosis and achieves response, but then progresses and receives lenalidomide/bortezomib after progression, these count as 2 separate regimens)
  • In cases of autologous stem cell transplant, the entire induction + stem cell mobilization + conditioning + planned maintenance should be considered one regimen
  • Patients may not have received any prior carfilzomib treatment
  • Patients must not be receiving any other concurrent therapy considered to be investigational; patients must not be planning to receive any radiotherapy (except localized radiation for palliative care); patients must not be planning to receive any concurrent chemotherapy, immunotherapy, radiotherapy or other treatment with curative intent
  • Patients must have complete history and physical examination within 28 days prior to registration
  • Patients must have baseline PET scan within 28 days prior to registration; note that images are submitted centrally for review
  • Patients with non-secretory MM or known primary amyloidosis are not eligible
  • Patients must have Zubrod performance status 0-2
  • Patients must not have clinically significant illness including uncontrolled, active infection requiring intravenous antibiotics, New York Heart Association (NYHA) class III or class IV heart failure, unstable angina pectoris, myocardial infarction within the past 6 months, or >= grade 3 cardiac arrhythmias
  • Patients must have undergone an electrocardiogram (EKG) within 28 days prior to registration
  • Patients must have either echocardiogram (ECHO) with ejection fraction >= 45% within 28 days prior to registration
  • Patients must not have > grade 2 neuropathy and/or POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
  • Total bilirubin =< 1.5 x upper limit of normal (ULN)
  • Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< 3 x ULN
  • Absolute neutrophil count (ANC) >= 1,000 cell/mm^3 without growth factor support within 14 days prior to registration
  • Platelets >= 50,000 cells/mm^3 for patients who have bone marrow plasmacytosis < 50% or >= 30,000 cells/mm^3 for patients who have bone marrow plasmacytosis of >= 50% within 14 days prior to registration
  • Calculated or measured creatinine clearance >= 30 ml/min within 14 days prior to registration
  • Patients who are known to be human immunodeficiency virus positive (HIV+) are eligible providing they meet all of the following additional criteria within 28 days prior to registration:
  • Cluster of differentiation (CD)4 cells >= 500/mm^3
  • Viral load of < 50 copies HIV messenger ribonucleic acid (mRNA)/mm^3 if on combination antiretroviral therapy (cART) or < 25,000 copies HIV mRNA if not on cART
  • No zidovudine or stavudine as part of cART
  • Patients who are HIV+ and do not meet all of these criteria are not eligible for this study
  • Patients with known hepatitis B or hepatitis C infection must have viral load < 800,000 IU/L within 28 days prior to registration
  • Patients must have baseline skeletal survey to document lytic lesions, osteopenia or compression fracture within 28 days prior to registration
  • Patients must be off myelosuppressive chemotherapy and non-myelosuppressive chemotherapy and external beam radiation therapy (XRT) for >= 28 days (>= 6 weeks for nitrosoureas) and must have recovered to =< grade 1 from all treatment associated toxicities prior to registration; patients are allowed to have treatment for up to 7 days with pulse steroids for a myeloma-related complication prior to registration, as considered necessary by the treating physician
  • Patients must be offered participation in specimen submission for translational medicine studies and banking; with patient consent, specimens must be submitted
  • Patients must not be pregnant or nursing; women/men of reproductive potential must have agreed to use an effective contraceptive method; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures
  • No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for three years
  • Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
  • REGISTRATION STEP 2: CROSSOVER
  • Patient must have been eligible for and initially randomized to Arm 1 (low dose carfilzomib) and progressed prior to completing 12 cycles of protocol therapy
  • At least 14 days and no more than 28 days must have elapsed between the last day of treatment on Arm 1 and registration to Arm 3
  • Patients must have recovered from all non-hematologic toxicities to =< grade 2 and from all hematologic toxicities to =< grade 3 prior to registration
  • Patients must have been able to complete their last treatment cycle prior to progression at the full assigned dose (i.e. no dose reduction for toxicity)
  • Patients must have serum protein electrophoresis (SPEP) and kappa and lambda light chain testing performed within 14 days prior to registration in order to establish baseline measurements
  • Patients must not have ejection fraction decrease > 10% from baseline (as determined by ECHO) or other ejection fraction decrease accompanied by other clinical signs/symptoms of New York Heart Association (NYHA) class III or IV heart failure, measured within 28 days prior to registration; if any question exists regarding individual patient eligibility in this situation, contact the study coordinator for determination

Trial Contact Information

Trial Lead Organizations/Sponsors

Southwest Oncology Group

  • National Cancer Institute
  • Onyx Pharmaceuticals, Incorporated
Sikander Ailawadhi, MD, Study Chair
Muneer Abidi, MD`, Study Chair
Cara Laubach
Ph: 210/614-8808 Ext.1027
Email: claubach@swog.org

Trial Sites

U.S.A.

California
Anaheim

Kaiser Permanente Medical Center - Anaheim/Orange County

Han A Koh
Ph: 626-564-3455

Antioch

Kaiser Permanente - Deer Valley

Tatjana Kolevska
Ph: 626-564-3455

Baldwin Park

Kaiser Permanente Medical Center - Baldwin Park

Han A Koh
Ph: 626-564-3455

Bellflower

Kaiser Permanente Medical Center - Bellflower

Han A Koh
Ph: 626-564-3455

Concord

Cancer Care Center at John Muir Health - Concord Campus

Kasra Karamlou
Ph: 925-674-2580

Fontana

Kaiser Permanente Medical Center - Fontana

Han A Koh
Ph: 626-564-3455

Fremont

Kaiser Permanente - Fremont

Tatjana Kolevska
Ph: 626-564-3455

Fresno

Kaiser Permanente Fresno Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Harbor City

Kaiser Permanente Medical Center - Harbor City

Han A Koh
Ph: 626-564-3455

Irvine

Kaiser Permanente - Irvine

Han A Koh
Ph: 626-564-3455

Los Angeles

Kaiser Foundation Hospital - West Los Angeles

Han A Koh
Ph: 626-564-3455

Kaiser Permanente Medical Center - Los Angeles

Han A Koh
Ph: 626-564-3455

USC/Norris Comprehensive Cancer Center and Hospital

Kevin R Kelly
Ph: 323-865-0451

Kevin R Kelly
Ph: 323-865-0451

Marysville

Fremont-Rideout Cancer Center

Joseph M. Tuscano
Ph: 916-734-3089

Modesto

Kaiser Permanente-Modesto

Tatjana Kolevska
Ph: 626-564-3455

Oakland

Kaiser Permanente-Oakland

Tatjana Kolevska
Ph: 626-564-3455

Orange

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center

Kanwarpal S Kahlon
Ph: 877-827-8839
Email: ucstudy@uci.edu

Panorama City

Kaiser Permanente Medical Group

Han A Koh
Ph: 626-564-3455

Redwood City

Kaiser Permanente Medical Center - Redwood City

Tatjana Kolevska
Ph: 626-564-3455

Richmond

Kaiser Permanente Medical Center - Richmond

Tatjana Kolevska
Ph: 626-564-3455

Riverside

Kaiser Permanente Medical Center - Riverside

Han A Koh
Ph: 626-564-3455

Roseville

Kaiser Permanente Medical Center - Roseville

Tatjana Kolevska
Ph: 626-564-3455

Sacramento

Kaiser Permanente Medical Center - Sacramento

Tatjana Kolevska
Ph: 626-564-3455

South Sacramento Kaiser-Permanente Medical Center

Tatjana Kolevska
Ph: 626-564-3455

University of California Davis Cancer Center

Joseph M. Tuscano
Ph: 916-734-3089

San Diego

Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego

Han A Koh
Ph: 626-564-3455

Kaiser Permanente Medical Office -Vandever Medical Office

Han A Koh
Ph: 626-564-3455

San Francisco

Kaiser Permanente Medical Center - San Francisco Geary Campus

Tatjana Kolevska
Ph: 626-564-3455

San Jose

Kaiser Permanente Medical Center - Santa Teresa

Tatjana Kolevska
Ph: 626-564-3455

San Leandro

Kaiser Permanente Medical Center - Hayward

Tatjana Kolevska
Ph: 626-564-3455

San Marcos

Kaiser Permanente Health Care

Han A Koh
Ph: 626-564-3455

San Rafael

Kaiser Foundation Hospital - San Rafael

Tatjana Kolevska
Ph: 626-564-3455

Santa Clara

Kaiser Permanente Medical Center - Santa Clara Homestead Campus

Tatjana Kolevska
Ph: 626-564-3455

Santa Rosa

Kaiser Permanente Medical Center - Santa Rosa

Tatjana Kolevska
Ph: 626-564-3455

South San Francisco

Kaiser Permanente Medical Center - South San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Stockton

Kaiser Permanente Medical Facility - Stockton

Tatjana Kolevska
Ph: 626-564-3455

Truckee

Tahoe Forest Cancer Center

Joseph M. Tuscano
Ph: 916-734-3089

Vacaville

Kaiser Permanente Medical Center - Vacaville

Tatjana Kolevska
Ph: 626-564-3455

Vallejo

Kaiser Permanente Medical Center - Vallejo

Tatjana Kolevska
Ph: 626-564-3455

Walnut Creek

John Muir/Mt. Diablo Comprehensive Cancer Center

Kasra Karamlou
Ph: 925-674-2580

Kaiser Permanente Medical Center - Walnut Creek

Tatjana Kolevska
Ph: 626-564-3455

Woodland Hills

Kaiser Permanente Medical Cener - Woodland Hills

Han A Koh
Ph: 626-564-3455

Connecticut
Hartford

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

New Haven

Yale Cancer Center

Madhav V Dhodapkar
Ph: 203-785-5702

Delaware
Lewes

Tunnell Cancer Center at Beebe Medical Center

Stephen Scott Grubbs
Ph: 302-733-6227

Newark

Christiana Gynecologic Oncology, LLC

Stephen Scott Grubbs
Ph: 302-733-6227

Delaware Clinical and Laboratory Physicians

Stephen Scott Grubbs
Ph: 302-733-6227

Helen F. Graham Cancer Center at Christiana Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Ph: 302-733-6227

Medical Oncology Hematology Consultants, PA at Helen F. Graham Cancer Center

Stephen Scott Grubbs
Ph: 302-733-6227

Regional Hematology/Oncology, PA - Newark

Stephen Scott Grubbs
Ph: 302-733-6227

Rehoboth Beach

Beebe Health Campus

Stephen Scott Grubbs
Ph: 302-733-6227

Seaford

Nanticoke Memorial Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Wilmington

Christiana Care Health System-Wilmington Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Florida
Gainesville

UF Health Cancer Center

Jan S. Moreb
Ph: 352-273-8675
Email: trials@cancer.ufl.edu

Jacksonville

Mayo Clinic - Jacksonville

Ronald S Go
Ph: 507-538-7623

Georgia
Savannah

Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler

O. George Negrea
Ph: 912-350-8568

Hawaii
Aiea

Kapiolani Medical Center at Pali Momi

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Ph: 808-586-2979

Honolulu

Cancer Research Center of Hawaii

Jeffrey L. Berenberg
Ph: 808-586-2979

Kaiser Permanente - Moanalua Medical Center and Clinic

Tatjana Kolevska
Ph: 626-564-3455

Kuakini Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

OnCare Hawaii, Incorporated - Kuakini

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Ph: 808-586-2979

OnCare Hawaii, Incorporated - Lusitana

Jeffrey L. Berenberg
Ph: 808-586-2979

Queen's Cancer Institute at Queen's Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Straub Clinic and Hospital, Incorporated

Jeffrey L. Berenberg
Ph: 808-586-2979

Lihue

Kauai Medical Clinic

Jeffrey L. Berenberg
Ph: 808-586-2979

Idaho
Boise

Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Coeur D'Alene

Kootenai Medical Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Post Falls

Kootenai Cancer Center - Post Falls

Benjamin Thomas Marchello
Ph: 800-648-6274

Sandpoint

Kootenai Cancer

Benjamin Thomas Marchello
Ph: 800-648-6274

Illinois
Bloomington

Illinois CancerCare - Bloomington

Nguyet A Le-Lindqwister
Ph: 800-793-2262

St. Joseph Medical Center

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Canton

Illinois CancerCare - Canton

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Carbondale

Memorial Hospital of Carbondale

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Carthage

Illinois CancerCare - Carthage

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Centralia

Centralia Oncology Clinic

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Danville

Carle on Vermilion

Wenqing Zhang
Ph: 800-446-5532

Decatur

Cancer Care Center of Decatur

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Decatur Memorial Hospital Cancer Care Institute

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Effingham

Carle Physician Group-Effingham

Wenqing Zhang
Ph: 800-446-5532

Crossroads Cancer Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Eureka

Illinois CancerCare - Eureka

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Galesburg

Galesburg Clinic, PC

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Medical and Surgical Specialists, LLC

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Kewanee

Illinois CancerCare - Kewanee Clinic

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Macomb

Illinois CancerCare - Macomb

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Mattoon

Carle Physician Group-Mattoon/Charleston

Wenqing Zhang
Ph: 800-446-5532

Maywood

Cardinal Bernardin Cancer Center at Loyola University Medical Center

Tulio E Rodriguez
Ph: 708-226-4357

Moline

Garneau, Stewart C MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Spector, David MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Trinity Cancer Center at Trinity Medical Center - 7th Street Campus

David M Spector
Ph: 309-779-4200

Mount Vernon

Good Samaritan Regional Health Center

Jay W Carlson
Ph: 800-821-7532

Ottawa

Illinois CancerCare - Ottawa

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Pekin

Cancer Treatment Center at Pekin Hospital

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Illinois CancerCare - Pekin

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Peoria

Illinois CancerCare - Peoria

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Methodist Medical Center of Illinois

Nguyet A Le-Lindqwister
Ph: 800-793-2262

OSF St. Francis Medical Center

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Peru

Illinois CancerCare - Princeton

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Princeton

Illinois CancerCare - Princeton

Nguyet A Le-Lindqwister
Ph: 800-793-2262

Rockford

Advanced Care and Treatment Medical Group, PC

Harvey Eric Einhorn
Ph: 779-696-9400
Email: cancercare@swedishamerican.org

Springfield

Regional Cancer Center at Memorial Medical Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Urbana

Carle Cancer Center at Carle Foundation Hospital

Wenqing Zhang
Ph: 800-446-5532

Wenqing Zhang
Ph: 800-446-5532

Indiana
Richmond

Reid Hospital & Health Care Services

Howard M. Gross
Ph: 937-775-1350

Iowa
Ames

McFarland Clinic, PC

Joseph James Merchant
Ph: 515-239-2621

William R. Bliss Cancer Center at Mary Greeley Medical Center

Joseph James Merchant
Ph: 515-239-2621

Bettendorf

Constantinou, Costas L MD (UIA Investigator)

David M Spector
Ph: 309-779-4200

Hematology Oncology Associates of the Quad Cities

Shobha R. Chitneni
Ph: 563-355-7733
Email: kedaprile@rccqc.com

Boone

McFarland Clinic PC-Boone

Joseph James Merchant
Ph: 515-239-2621

Davenport

Genesis Regional Cancer Center at Genesis Medical Center

George Kovach
Ph: 800-446-6088
Email: werners@genesishealth.com

Des Moines

CCOP - Iowa Oncology Research Association

Robert J Behrens
Ph: 515-282-2921

John Stoddard Cancer Center at Iowa Lutheran Hospital

Robert J Behrens
Ph: 515-282-2921

John Stoddard Cancer Center at Iowa Methodist Medical Center

Robert J Behrens
Ph: 515-282-2921

Medical Oncology and Hematology Associates at John Stoddard Cancer Center

Robert J Behrens
Ph: 515-282-2921

Fort Dodge

Trinity Regional Medical Center

Joseph James Merchant
Ph: 515-239-2621

Jefferson

McFarland Clinic PC-Jefferson

Joseph James Merchant
Ph: 515-239-2621

Marshalltown

McFarland Clinic PC-Marshalltown

Joseph James Merchant
Ph: 515-239-2621

Sioux City

Siouxland Hematology-Oncology Associates, LLP

Donald Bruce Wender
Ph: 712-252-0088

West Des Moines

Methodist West Hospital

Robert J Behrens
Ph: 515-282-2921

Kansas
Chanute

Cancer Center of Kansas, PA - Chanute

Shaker R. Dakhil
Ph: 316-262-4467

Dodge City

Cancer Center of Kansas, PA - Dodge City

Shaker R. Dakhil
Ph: 316-262-4467

El Dorado

Cancer Center of Kansas, PA - El Dorado

Shaker R. Dakhil
Ph: 316-262-4467

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-262-4467

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-262-4467

Kingman

Cancer Center of Kansas, PA - Kingman

Shaker R. Dakhil
Ph: 316-262-4467

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-262-4467

Liberal

Cancer Center of Kansas, PA - Liberal

Shaker R. Dakhil
Ph: 316-262-4467

Newton

Cancer Center of Kansas, PA - Newton

Shaker R. Dakhil
Ph: 316-262-4467

Parsons

Cancer Center of Kansas, PA - Parsons

Shaker R. Dakhil
Ph: 316-262-4467

Pratt

Cancer Center of Kansas, PA - Pratt

Shaker R. Dakhil
Ph: 316-262-4467

Salina

Cancer Center of Kansas, PA - Salina

Shaker R. Dakhil
Ph: 316-262-4467

Wellington

Cancer Center of Kansas, PA - Wellington

Shaker R. Dakhil
Ph: 316-262-4467

Wichita

Associates in Women's Health, PA - North Hillside

Shaker R. Dakhil
Ph: 316-262-4467

Cancer Center of Kansas, PA - Medical Arts Tower

Shaker R. Dakhil
Ph: 316-262-4467

Cancer Center of Kansas, PA - Wichita

Shaker R. Dakhil
Ph: 316-262-4467

Via Christi Cancer Center at Via Christi Regional Medical Center

Shaker R. Dakhil
Ph: 316-262-4467

Winfield

Cancer Center of Kansas, PA - Winfield

Shaker R. Dakhil
Ph: 316-262-4467

Kentucky
Crestview Hills

Oncology Hematology Care, Incorporated - Crestview Hills

Howard M. Gross
Ph: 937-775-1350

Maine
Augusta

Harold Alfond Center for Cancer Care

Thomas Henry Openshaw
Ph: 207-973-4274

Bangor

CancerCare of Maine at Eastern Maine Medical Center

Thomas Henry Openshaw
Ph: 207-973-4274

Rockport

Penobscot Bay Medical Center Cancer Care Center

Thomas Henry Openshaw
Ph: 207-973-4274

Maryland
Salisbury

Peninsula Regional Medical Center

Paul E Zorsky
Ph: 410-543-7017
Email: sandra.heineken@peninsula.org

Massachusetts
Beverly

Beverly Hospital

Angus P. McIntyre
Ph: 978-283-4000ext559

Burlington

Lahey Clinic Medical Center - Burlington

Tarun Kewalramani
Ph: 781-744-8027

Gloucester

Addison Gilbert Hospital

Angus P. McIntyre
Ph: 978-283-4000ext559

Michigan
Adrian

Hickman Cancer Center at Bixby Medical Center

Rex B Mowat
Ph: 800-444-3561

Ann Arbor

Saint Joseph Mercy Cancer Center

Christopher M Reynolds
Ph: 734-712-4673

Dearborn

Oakwood Cancer Center at Oakwood Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Detroit

Van Elslander Cancer Center at St. John Hospital and Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Wayne State University

Jeffrey A. Zonder
Ph: 313-576-9363

Escanaba

Green Bay Oncology, Limited - Escanaba

Matthew L Ryan
Ph: 800-432-6049

Farmington Hills

Weisberg Cancer Treatment Center

Jeffrey A. Zonder
Ph: 313-576-9363

Flint

Genesys Hurley Cancer Institute

Christopher M Reynolds
Ph: 734-712-4673

Hurley Medical Center

Christopher M Reynolds
Ph: 734-712-4673

Iron Mountain

Green Bay Oncology - Iron Mountain

Matthew L Ryan
Ph: 800-432-6049

Jackson

Gayle M. Jacob Cancer Center at Allegiance Health

Christopher M Reynolds
Ph: 734-712-4673

Kalamazoo

Borgess Medical Center

Raymond Sterling Lord
Ph: 269-373-7458

Bronson Methodist Hospital

Raymond Sterling Lord
Ph: 269-373-7458

West Michigan Cancer Center

Raymond Sterling Lord
Ph: 269-373-7458

Lansing

Sparrow Regional Cancer Center

Christopher M Reynolds
Ph: 734-712-4673

Livonia

St. Mary Mercy Hospital

Christopher M Reynolds
Ph: 734-712-4673

Monroe

Community Cancer Center of Monroe

Rex B Mowat
Ph: 800-444-3561

Pontiac

St. Joseph Mercy Oakland

Christopher M Reynolds
Ph: 734-712-4673

Port Huron

Mercy Regional Cancer Center at Mercy Hospital

Christopher M Reynolds
Ph: 734-712-4673

Saginaw

Seton Cancer Institute at Saint Mary's - Saginaw

Christopher M Reynolds
Ph: 734-712-4673

Southfield

Providence Hospital - Southfield

Howard R. Terebelo
Ph: 248-849-5337
Email: jaswinder.grewal@stjohn.org

Warren

St. John Macomb Hospital

Christopher M Reynolds
Ph: 734-712-4673

Minnesota
Bemidji

MeritCare Bemidji

Preston D. Steen
Ph: 701-234-6161

Burnsville

Fairview Ridges Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Coon Rapids

Mercy and Unity Cancer Center at Mercy Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Edina

Fairview Southdale Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Fridley

Mercy and Unity Cancer Center at Unity Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Hutchinson

Hutchinson Area Health Care

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Maplewood

HealthEast Cancer Care at St. John's Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Minnesota Oncology - Maplewood

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Minneapolis

Health Partners Inc

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Hennepin County Medical Center - Minneapolis

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

New Ulm

New Ulm Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Robbinsdale

Humphrey Cancer Center at North Memorial Outpatient Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Rochester

Mayo Clinic Cancer Center

Ronald S Go
Ph: 507-538-7623

Saint Louis Park

Park Nicollet Cancer Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Saint Paul

Regions Hospital Cancer Care Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

United Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Shakopee

St. Francis Cancer Center at St. Francis Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Stillwater

Lakeview Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Waconia

Ridgeview Medical Center

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Willmar

Willmar Cancer Center at Rice Memorial Hospital

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Woodbury

Minnesota Oncology - Woodbury

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Mississippi
Jackson

University of Mississippi Cancer Clinic

Tondre T Buck
Ph: 601-815-6700

Missouri
Bonne Terre

Parkland Health Center-Bonne Terre

Bryan A Faller
Ph: 800-392-0936

Branson

Skaggs Cancer Center at Skaggs Regional Medical Center

Jay W Carlson
Ph: 800-821-7532

Cape Girardeau

Saint Francis Medical Center

James L. Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

Southeast Cancer Center

Alan Philip Lyss
Ph: 800-392-0936

Chesterfield

Saint Luke's Hospital

Donald F. Busiek
Ph: 314-205-6936

Jefferson City

Goldschmidt Cancer Center

Alan Philip Lyss
Ph: 800-392-0936

Joplin

Freeman Cancer Institute at Freeman Health System

Jay W Carlson
Ph: 800-821-7532

Rolla

Mercy Clinic Cancer and Hematology - Rolla

Jay W Carlson
Ph: 800-821-7532

Phelps County Regional Medical Center

Jay W Carlson
Ph: 800-821-7532

Saint Louis

David C. Pratt Cancer Center at St. John's Mercy

Jay W Carlson
Ph: 800-821-7532

Mercy Clinic St. Louis Cancer and Breast Institute

Jay W Carlson
Ph: 800-821-7532

Missouri Baptist Cancer Center

Alan Philip Lyss
Ph: 800-392-0936

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

Bryan A Faller
Ph: 800-392-0936

Springfield

Hulston Cancer Center at Cox Medical Center South

Jay W Carlson
Ph: 800-821-7532

St. John's Regional Health Center

Jay W Carlson
Ph: 800-821-7532

Sullivan

Missouri Baptist Sullivan Hospital

Bryan A Faller
Ph: 800-392-0936

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

Bryan A Faller
Ph: 800-392-0936

Montana
Billings

Billings Clinic Cancer Center - 801 N 29th Street

Benjamin Thomas Marchello
Ph: 800-648-6274

CCOP - Montana Cancer Consortium

Benjamin Thomas Marchello
Ph: 800-648-6274

St. Vincent Healthcare Cancer Care Services

Benjamin Thomas Marchello
Ph: 800-648-6274

Bozeman

Bozeman Deaconess Cancer Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Butte

St. James Healthcare Cancer Care

Benjamin Thomas Marchello
Ph: 800-648-6274

Great Falls

Benefis Sletten Cancer Institute

Benjamin Thomas Marchello
Ph: 800-648-6274

Helena

St. Peter's Hospital

Benjamin Thomas Marchello
Ph: 800-648-6274

Kalispell

Kalispell Regional Medical Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Missoula

Community Medical Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Nevada
Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 702-384-0013

Las Vegas Cancer Center - Henderson

John Allan Ellerton
Ph: 702-384-0013

Las Vegas

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 702-384-0013

21st Century Oncology - Vegas Sunrise

John Allan Ellerton
Ph: 702-384-0013

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Fort Apache

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 702-384-0013

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 702-384-0013

Cancer Institute of Nevada at Summerlin Hospital Medical Center

John Allan Ellerton
Ph: 702-384-0013

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 702-384-0013

CCOP - Nevada Cancer Research Foundation

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 702-384-0013

Comprehensive Cancer Centers of Nevada - Southwest

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 702-384-0013

Radiation Oncology Centers of Las Vegas - Downtown Location

John Allan Ellerton
Ph: 702-384-0013

Radiation Oncology Centers of Las Vegas - Eastern Location

John Allan Ellerton
Ph: 702-384-0013

University Medical Center of Southern Nevada

John Allan Ellerton
Ph: 702-384-0013

New Jersey
Vineland

Frank and Edith Scarpa Regional Cancer Pavillion at South Jersey Healthcare

Tami L Bach
Ph: 856-641-7933

Woodbury

Underwood Memorial Hospital

Carl J. Minniti
Ph: 856-641-7933

New York
Middletown

Tucker Center for Cancer Care at Orange Regional Medical Center

Jeffrey M. Stewart
Ph: 845-342-7609

North Carolina
Asheboro

Randolph Hospital

James M Granfortuna
Ph: 336-832-0821

Burlington

Alamance Cancer Center at Alamance Regional Medical Center

James M Granfortuna
Ph: 336-832-0821

Chapel Hill

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

Peter M Voorhees
Ph: 877-668-0683
Email: cancerclinicaltrials@med.unc.edu

Clinton

Southeastern Medical Oncology Center-Clinton

James N. Atkins
Ph: 919-580-0000

Goldsboro

Southeastern Medical Oncology Center - Goldsboro

James N. Atkins
Ph: 919-580-0000

Wayne Memorial Hospital, Incorporated

James N. Atkins
Ph: 919-580-0000

Greensboro

Moses Cone Regional Cancer Center at Wesley Long Community Hospital

James M Granfortuna
Ph: 336-832-0821

Hendersonville

Comprehensive Cancer Center at Pardee Hospital

James E. Radford
Ph: 828-696-4716

Hendersonville Hematology and Oncology

James E. Radford
Ph: 828-696-4716

Jacksonville

Southeastern Medical Oncology Center-Jacksonville

James N. Atkins
Ph: 919-580-0000

Kinston

Kinston Medical Specialists

Peter R. Watson
Ph: 252-559-2200

Mebane

Cone Heath Cancer Center at Mebane

James M Granfortuna
Ph: 336-832-0821

Reidsville

Annie Penn Cancer Center

James M Granfortuna
Ph: 336-832-0821

Statesville

Iredell Memorial Hospital

Ruby A. Grimm
Ph: 704-873-5661

Wilson

Southeastern Medical Oncology Center - Wilson

James N. Atkins
Ph: 919-580-0000

Winston-Salem

Wake Forest University Comprehensive Cancer Center

Rakhee Vaidya
Ph: 336-713-6771

North Dakota
Bismarck

Medcenter One Hospital Cancer Care Center

Preston D. Steen
Ph: 701-234-6161

Fargo

Roger Maris Cancer Center at MeritCare Hospital

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Ph: 701-234-6161

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Ohio
Belpre

Strecker Cancer Center-Belpre

J. Philip Kuebler
Ph: 800-446-5532

Canton

Aultman Cancer Center at Aultman Hospital

James A. Schmotzer
Ph: 330-363-6891

Centerville

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350

Chillicothe

Adena Regional Medical Center

J. Philip Kuebler
Ph: 800-446-5532

Cincinnati

Oncology Hematology Care Inc - Western Hills

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Anderson

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Blue Ash

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Kenwood

Howard M. Gross
Ph: 937-775-1350

Oncology Hematology Care, Incorporated - Mt. Auburn/Taft Road

Howard M. Gross
Ph: 937-775-1350

Columbus

Columbus Oncology Associates, Incorporated

J. Philip Kuebler
Ph: 800-446-5532

Doctors Hospital at Ohio Health

J. Philip Kuebler
Ph: 800-446-5532

Grant Medical Center Cancer Care

J. Philip Kuebler
Ph: 800-446-5532

Mount Carmel Health - West Hospital

J. Philip Kuebler
Ph: 800-446-5532

Riverside Methodist Hospital Cancer Care

J. Philip Kuebler
Ph: 800-446-5532

Zangmeister Center

J. Philip Kuebler
Ph: 800-446-5532

Dayton

David L. Rike Cancer Center at Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Good Samaritan Hospital

Howard M. Gross
Ph: 937-775-1350

Samaritan North Cancer Care Center

Howard M. Gross
Ph: 937-775-1350

Delaware

Delaware Health Center

J. Philip Kuebler
Ph: 800-446-5532

Delaware Radiation Oncology

J. Philip Kuebler
Ph: 614-566-3275

Grady Memorial Hospital

J. Philip Kuebler
Ph: 800-446-5532

Fairfield

Oncology Hematology Care, Incorporated - Fairfield Healthplex

Howard M. Gross
Ph: 937-775-1350

Findlay

Blanchard Valley Regional Cancer Center

Howard M. Gross
Ph: 937-775-1350

Franklin

Atrium Medical Center

Howard M. Gross
Ph: 937-775-1350

Greenville

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350

Kettering

Charles F. Kettering Memorial Hospital

Howard M. Gross
Ph: 937-775-1350

Lancaster

Fairfield Medical Center

J. Philip Kuebler
Ph: 800-446-5532

Marietta

Strecker Cancer Center at Marietta Memorial Hospital

J. Philip Kuebler
Ph: 800-446-5532

Maumee

Northwest Ohio Oncology Center

Rex B Mowat
Ph: 800-444-3561

Rex B Mowat
Ph: 800-444-3561

Mount Vernon

Knox Community Hospital

J. Philip Kuebler
Ph: 800-446-5532

Newark

Licking Memorial Cancer Care Program at Licking Memorial Hospital

J. Philip Kuebler
Ph: 800-446-5532

Newark Radiation Oncology

J. Philip Kuebler
Ph: 614-566-3275

Oregon

St. Charles Mercy Hospital

Rex B Mowat
Ph: 800-444-3561

Portsmouth

Southern Ohio Medical Center Cancer Center

J. Philip Kuebler
Ph: 800-446-5532

Springfield

Community Hospital of Springfield and Clark County

J. Philip Kuebler
Ph: 800-446-5532

Sylvania

Flower Hospital Cancer Center

Rex B Mowat
Ph: 800-444-3561

Toledo

CCOP - Toledo Community Hospital

Rex B Mowat
Ph: 800-444-3561

St. Anne Mercy Hospital

Rex B Mowat
Ph: 800-444-3561

Toledo Clinic, Incorporated - Main Clinic

Rex B Mowat
Ph: 800-444-3561

University of Toledo Medical Center

Rex B Mowat
Ph: 800-444-3561

Troy

UVMC Cancer Care Center at Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350

Westerville

Mount Carmel St. Ann's Cancer Center

J. Philip Kuebler
Ph: 800-446-5532

Wright-Patterson Afb

United States Air Force Medical Center - Wright-Patterson

Brandon J Cutler
Ph: 937-257-1398

Zanesville

Genesis - Good Samaritan Hospital

J. Philip Kuebler
Ph: 800-446-5532

Oklahoma
Oklahoma City

Stephenson Cancer Center at the University of Oklahoma

George B Selby
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

Pennsylvania
Bryn Mawr

Bryn Mawr Hospital

Albert S DeNittis
Ph: 866-225-5654

Danville

Geisinger Cancer Institute at Geisinger Health

Edward J Gorak
Ph: 570-271-5251

Hazleton

Geisinger Hazleton Cancer Center

Edward J Gorak
Ph: 570-271-5251

Lewisburg

Geisinger Medical Oncology at Evangelical Community Hospital

Edward J Gorak
Ph: 570-271-5251

Lewistown

Lewistown Hospital

Edward J Gorak
Ph: 570-271-5251

Media

Riddle Memorial Hospital Cancer Center

Albert S DeNittis
Ph: 866-225-5654

Paoli

Cancer Center of Paoli Memorial Hospital

Albert S DeNittis
Ph: 866-225-5654

Philadelphia

Abramson Cancer Center of the University of Pennsylvania

Adam D Cohen
Ph: 800-474-9892

Fox Chase Cancer Center - Philadelphia

Patricia L Kropf
Ph: 215-728-4790

Pottsville

Geisinger Medical Oncology-Pottsville

Edward J Gorak
Ph: 570-271-5251

Reading

St. Joseph Medical Center

Marc Rovito
Ph: 610-378-2336
Email: danielward2@catholichealth.net

Sellersville

Grand View Hospital

Anthony J Magdalinski
Ph: 215-453-4162
Email: PParsons@gvh.org

State College

Geisinger Medical Group - Scenery Park

Edward J Gorak
Ph: 570-271-5251

West Reading

McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center

Terrence P. Cescon
Ph: 610-988-9323

Wilkes-Barre

Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center

Edward J Gorak
Ph: 570-271-5251

Wynnewood

Lankenau Cancer Center at Lankenau Hospital

Albert S DeNittis
Ph: 866-225-5654

South Carolina
Anderson

AnMed Cancer Center

John E Doster
Ph: 864-512-1000

Florence

McLeod Regional Medical Center

Rajesh Bajaj
Ph: 843-679-7256

South Dakota
Sioux Falls

Sanford Cancer Center at Sanford USD Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Ph: 701-234-6161

Texas
Houston

Univeristy of Texas M.D. Anderson Cancer Center

Robert Zygmunt Orlowski
Ph: 713-792-3245

Washington
Seattle

Virginia Mason Medical Center

Prakash Vishnu
Ph: 206-342-6954
Email: vmmc.cancer_clinical_research@VirginiaMason.org

Wisconsin
Burlington

Aurora Cancer Care-Burlington

Dhimant R. Patel
Ph: 800-252-2990

Elkhorn

Vince Lombardi Cancer Center at Aurora Lakeland Medical Center - Elkhorn

Dhimant R. Patel
Ph: 800-252-2990

Fond Du Lac

Aurora Health Center-Fond du Lac

Dhimant R. Patel
Ph: 800-252-2990

Grafton

Aurora Cancer Care-Grafton

Dhimant R. Patel
Ph: 800-252-2990

Green Bay

Green Bay Oncology, Limited at St. Mary's Hospital

Matthew L Ryan
Ph: 800-432-6049

Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center

Matthew L Ryan
Ph: 800-432-6049

St. Mary's Hospital Medical Center - Green Bay

Matthew L Ryan
Ph: 800-432-6049

St. Vincent Hospital Regional Cancer Center

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Green Bay at Aurora BayCare Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Kenosha

Oncology Alliance - Kenosha South

Dhimant R. Patel
Ph: 800-252-2990

Manitowoc

Holy Family Memorial Medical Center Cancer Care Center

Matthew L Ryan
Ph: 800-432-6049

Marinette

Bay Area Cancer Care Center at Bay Area Medical Center

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Marinette

Dhimant R. Patel
Ph: 800-252-2990

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Dhimant R. Patel
Ph: 800-252-2990

Milwaukee

Aurora Cancer Care-Milwaukee

Dhimant R. Patel
Ph: 800-252-2990

Aurora Sinai Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Oncology Alliance, SC - Milwaukee - South

Dhimant R. Patel
Ph: 800-252-2990

Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Mukwonago

D.N. Greenwald Center

Timothy R Wassenaar
Ph: 262-928-7878

New Richmond

Cancer Center of Western Wisconsin

Patrick J. Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Oconomowoc

Regional Cancer Center at Oconomowoc Memorial Hospital

Timothy R Wassenaar
Ph: 262-928-7878

Oconto Falls

Green Bay Oncology, Limited - Oconto Falls

Matthew L Ryan
Ph: 800-432-6049

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Dhimant R. Patel
Ph: 800-252-2990

Racine

Aurora Health Center - Racine

Dhimant R. Patel
Ph: 800-252-2990

Sheboygan

Saint Nicholas Hospital

Matthew L Ryan
Ph: 800-432-6049

Vince Lombardi Cancer Clinic - Sheboygan

Dhimant R. Patel
Ph: 800-252-2990

Sturgeon Bay

Green Bay Oncology, Limited - Sturgeon Bay

Matthew L Ryan
Ph: 800-432-6049

Summit

Aurora Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Two Rivers

Vince Lombardi Cancer Clinic - Two Rivers

Dhimant R. Patel
Ph: 800-252-2990

Waukesha

Aurora Cancer Care-Waukesha

Dhimant R. Patel
Ph: 800-252-2990

Waukesha Memorial Hospital Regional Cancer Center

Timothy R Wassenaar
Ph: 262-928-7878

Wauwatosa

Oncology Alliance, SC - Milwaukee - West

Dhimant R. Patel
Ph: 800-252-2990

West Allis

Aurora Women's Pavilion of West Allis Memorial Hospital

Dhimant R. Patel
Ph: 800-252-2990

Wyoming
Cody

Big Horn Basin Cancer Center

Benjamin Thomas Marchello
Ph: 800-648-6274

Billings Clinic-Cody

Benjamin Thomas Marchello
Ph: 800-648-6274

Sheridan

Welch Cancer Center at Sheridan Memorial Hospital

Benjamin Thomas Marchello
Ph: 800-648-6274

Link to the current ClinicalTrials.gov record.
NLM Identifier NCT01903811
ClinicalTrials.gov processed this data on March 08, 2015

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.